Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Clinical trial NCT07080385 · RECRUITING
Trial details
- NCT number
- NCT07080385
- Sponsor
- Calcilytix Therapeutics, Inc., a BridgeBio company
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2028-12-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.